|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Surgical management of chronic total occlusion of abdominal aorta显示文摘 | Mavioglu I Veli Dogan O Ozeren M | 2003 | J Cardiovasc Surg (Torino)2003,44,1: | 1 |
| 2 | Effect of paclobutrazoI on flowering,leaf and flower colour of Consolid orientalis显示文摘 | Sibel M Osman K Veli O | 2009 | Pak J Bot2009,41,23: | 1 |
| 3 | Aptamers: molecular tools for analytical applications显示文摘 | Teresa Mairal Veli Cengiz ?zalp Pablo Lozano Sánchez Mònica Mir Ioanis Katakis Ciara K. O’Sullivan | 2008 | Analytical and Bioanalytical Chemistry2008,,4: | 1 |
| 4 | Sparse-spike AVO/AVA at- tributes from prestaek data显示文摘 | Perez O D Velis R D | 2011 | Expanded Abstracts of 81s'' Annual Internat SEG Mtg2011,,: | 1 |
| 5 | Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by Fc gamma RⅡB 显示文摘 | BRUHNS P VELY F MALBEC O | 2000 | J Biol Chem2000,275,48: | 1 |
| 6 | OPG and RANKL levels around minis crew implants during orthodontic tooth movement显示文摘 | Enhos S Veli 1 Cakmak O | 2013 | Am J Orthod Dentofacial Orthop2013,144,2: | 1 |
| 7 | Purification of major lignin peroxidase isoenzymes from Phanerochaete chrysosporium by chromatofo-cusing显示文摘 | Veli M L Tero A | 1995 | Protein Expression and Purification1995,6,: | 1 |
| 8 | Surgical management of chronic total occlusion of abdominal aorta 显示文摘 | Mavioglu I Veli Dogan O Ozeren M | 2003 | J Cardiovase Surg2003,44,1: | 1 |
| 9 | Effects of packing method and storage time on the chemical microbiological and sensory properties of Turkish pastirma-A dry cured beef product显示文摘 | Veli G Ersel O Levent A | 2008 | Meat Science2008,80,2: | 1 |
| 10 | An estimation of the recreational use value of Kursunlu Waterfall Nature Park by the individual travel cost method显示文摘 | Veli O Burhan O Osman K | 2002 | Turk J Agric2002,26,: | 1 |
| 11 | Photosystem Ⅱ and cellular membrane stability evaluation in hexaploid wheat seedling under salt stress conditions显示文摘 | VELI C O HUSEYIN A O SYED M S N | 2000 | Journal of Plant Nutrition2000,23,2: | 1 |
| 12 | The launch of the European Institute for innovation through health data显示文摘The European Institute for Innovation through Health Data (i^HD) has been formed as one of the sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR) and SemanticHealthNet projects, in collaboration with other European Commission projects and initiatives. The vision of i^HD is to become the European organisation of reference for guiding and catalysing the best, most efficient and trustworthy uses of health data and interoperability, for optimizing health and knowledge discovery. i^HD has been established in recognition that there is a need to tackle areas of challenge in the successful scaling up of innovations that rely on high-quality and interoperable health data, to sustain and propagate the results of eHealth research, and to address current-day obstacles to using health data. i^HD was launched at an inaugural conference in Paris, in March 2016. This was attended by over 200 European clinicians, healthcare providers and researchers, representatives of the pharma industry, patient associations, health professional associations, the health ICT industry and standards bodies. The event showcased issues and approaches, that are presented in this paper to highlight the activities that i^HD intends to pursue as enablers of the better uses of health data, for care and research. | Dipak Kalra Mats Sundgren Brecht Claerhout Pierre Meulien Bart Vannieuwenhuyse Peter Singleton Terje Peetso Veli Stroetmann Petra Wilson Mary Baker Pascal Coorevits John O’Brien Georges De Moor | 2016 | Journal of Medicines Development Sciences2016,2,2: | 0 |
| 13 | The Launch of the European Institute for Innovation through Health Data显示文摘The European Institute for Innovation through Health Data (i ~HD) has been formed as one of the sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR) and SemanticHealthNet projects,in collaboration with other European Commission projects and initiatives.The vision of i^HD is to become the European organisation of reference for guiding and catalysing the best,most efficient and trustworthy uses of health data and interoperability,for optimizing health and knowledge discovery.i^HD has been established in recognition that there is a need to tackle areas of challenge in the successful scaling up of innovations that rely on high-quality and interoperable health data,to sustain and propagate the results of eHealth research,and to address current-day obstacles to using health data.i^HD was launched at an inaugural conference in Paris,in March 2016.This was attended by over 200 European clinicians,healthcare providers and researchers,representatives of the pharma industry,patient associations,health professional associations,the health ICT industry and standards bodies.The event showcased issues and approaches,that are presented in this paper to highlight the activities that i^HD intends to pursue as enablers of the better uses of health data,for care and research. | Dipak Kalra Mats Sundgren Brecht Claerhout Pierre Meulien Bart Vannieuwenhuyse Peter Singleton Terje Peetso Veli Stroetmann Petra Wilson Mary Baker Pascal Coorevits John O’Brien Georges De Moor | 2018 | Journal of Medicines Development Sciences2018,3,1: | 0 |